Immunotherapy Backed as Standard First-line Treatment for Head and Neck Cancer
Immunotherapy pembrolizumab keeps some patients alive for three years or more Pembrolizumab either used alone or in combination with chemotherapy…
Cancer
Can Thermal Imaging Detect Breast Cancer?
If Bal Gill had not chosen to visit the Camera Obscura and World of Illusions at Edinburgh’s Royal Mile earlier…
And Life Goes On
It is a while since I have written a blog. My disease has been stable for just over a year…
The Continued Evolution of Prostate Cancer Screening
New data will offer a unique insight into whether prostate MRI could be the test that we are looking for…
UK Mouth Cancer Rates Hit Record High
New cases of mouth cancer in the United Kingdom have risen to a record high, according to the findings of…
Rise in Liver Cancer Diagnoses in UK Driven by Alcohol and Obesity
The British Liver Trust has warned that damage to the liver caused by alcohol and unhealthy lifestyles is leading to…
Inaugural London Global Cancer Week
The inaugural London Global Cancer Week will launch at the Royal Society of Medicine on Monday 25 November. The week-long…
New Evolution-busting Drug Overcomes Resistance in Aggressive Breast Cancers
A new type of drug that blocks one of cancer’s key evolutionary escape routes from chemotherapy could be used to…
Gut Bacteria “Fingerprint” Predicts Radiotherapy Side Effects
· First clinical study to show link between types of gut bacteria and radiotherapy-induced gut damage · Studying patients’ bacterial…
Olaparib Outperforms Targeted Hormone Therapy in Men with Advanced Prostate Cancer
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving…